Cargando…

Development and Validation of a Novel Diagnostic Nomogram Model Using Serum Oxidative Stress Markers and AURKA for Prediction of Nasopharyngeal Carcinoma

PURPOSE: The mortality rate of nasopharyngeal carcinoma (NPC) remains high due to the absence of quick and accurate diagnostic approaches at its early stage. Our aim is to evaluate the diagnostic value of the elevated expression of Aurora kinase A (AURKA) and the oxidative stress markers (such as gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jiahui, Luo, Huidan, Wang, Kun, Yi, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544130/ https://www.ncbi.nlm.nih.gov/pubmed/37790897 http://dx.doi.org/10.2147/CMAR.S402572

Ejemplares similares

The role of Exosomes in the Pathogenesis of Nasopharyngeal Carcinoma and the involved Clinical Application
por: Luo, Huidan, et al.
Publicado: (2021)

Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells
por: Yang, Yan, et al.
Publicado: (2020)

Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma
por: Jiang, Yanming, et al.
Publicado: (2020)

AURKA inhibition mimics BRCAness
por: Hirst, Jeff, et al.
Publicado: (2017)

Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas
por: Chen, Yuan, et al.
Publicado: (2019)

RNA-binding protein YBX1 promotes cell proliferation and invasiveness of nasopharyngeal carcinoma cells via binding to AURKA mRNA
por: Ban, Yuanyuan, et al.
Publicado: (2021)

Impacts of AURKA Genetic Polymorphism on Urothelial Cell Carcinoma Development
por: Huang, Chia-Hung, et al.
Publicado: (2019)

Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma Patients after Definitive Radiotherapy
por: Yang, Lin, et al.
Publicado: (2015)

Development and Validation of a Prognostic Nomogram Based on Residual Tumor in Patients With Nondisseminated Nasopharyngeal Carcinoma
por: Liao, Ping-Yan, et al.
Publicado: (2020)

Development and Validation of a Nomogram for Predicting Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma
por: Guan, Wenqiang, et al.
Publicado: (2020)

Bioinformatics and experimental validation of an AURKA/TPX2 axis as a potential target in esophageal squamous cell carcinoma
por: Du, Ruijuan, et al.
Publicado: (2023)

Development of Prognostic Nomogram Based on Lipid Metabolic Markers and Lactate Dehydrogenase in Non-Metastatic Nasopharyngeal Carcinoma
por: Huang, Rong, et al.
Publicado: (2023)

External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma
por: Yip, Pui-Lam, et al.
Publicado: (2021)

Construction of nomograms for nasopharyngeal carcinoma containing primary tumor size and SEER stage
por: Yang, Guangrong, et al.
Publicado: (2020)

Integrated pan‐cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance
por: Miralaei, Noushin, et al.
Publicado: (2021)

Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma
por: Zhang, Lu-Lu, et al.
Publicado: (2020)

Radiomic Nomogram: Pretreatment Evaluation of Local Recurrence in Nasopharyngeal Carcinoma based on MR Imaging
por: Zhang, Lu, et al.
Publicado: (2019)

Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers
por: Yang, Chuang, et al.
Publicado: (2023)

Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2020)

A Nomogram Based on Serum Biomarkers and Clinical Characteristics to Predict Survival in Patients With Non-Metastatic Nasopharyngeal Carcinoma
por: Li, Qing-Jie, et al.
Publicado: (2020)

Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma
por: Tan, Gongjun, et al.
Publicado: (2016)

Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment
por: Liang, Wenhua, et al.
Publicado: (2016)

Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases
por: Lin, Chao, et al.
Publicado: (2020)

Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers
por: An, Shu, et al.
Publicado: (2023)

Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
por: Wu, Shixiu, et al.
Publicado: (2015)

A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis
por: Zeng, Zixun, et al.
Publicado: (2016)

A Nomogram for the Prediction of Prognosis in Patients With Distant Metastases of Nasopharyngeal Carcinoma
por: Zhao, Liang, et al.
Publicado: (2019)

The role of AURKA/miR‐199b‐3p in hepatocellular carcinoma cells
por: Li, Guogang, et al.
Publicado: (2022)

Development and validation of a nomogram for predicting long-term overall survival in nasopharyngeal carcinoma: A population-based study
por: Wu, Jiayuan, et al.
Publicado: (2020)

Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area
por: Yao, Ji-Jin, et al.
Publicado: (2021)

Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers
por: Hu, Zili, et al.
Publicado: (2022)

Predicting AURKA as a novel therapeutic target for NPC: A comprehensive analysis based on bioinformatics and validation
por: Huang, Chaobin, et al.
Publicado: (2022)

The Variation and Correlation of Serum Adiponectin, Nesfatin-1, IL-6, and TNF-α Levels in Prediabetes
por: Huang, Kangkang, et al.
Publicado: (2022)

Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics
por: Li, Jianpei, et al.
Publicado: (2018)

Inactivation of HMGCL promotes proliferation and metastasis of nasopharyngeal carcinoma by suppressing oxidative stress
por: Luo, Wenqi, et al.
Publicado: (2017)

Serum Oxidative and Nitrosative Stress Markers in Clear Cell Renal Cell Carcinoma
por: Galiniak, Sabina, et al.
Publicado: (2023)

Over-expression of AURKA, SKA3 and DSN1 contributes to colorectal adenoma to carcinoma progression
por: Chuang, Tzu-Po, et al.
Publicado: (2016)

LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation
por: Wang, Yingchao, et al.
Publicado: (2023)

Accuracy Evaluation and Comparison of 14 Diagnostic Markers for Nasopharyngeal Carcinoma: A Meta-Analysis
por: Feng, Yiwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e9te8ttoi0c75tqsokf283pbtm